BioSpace

ObesityWeek 2026: Wave outlines case for body composition–based trial design

Across three cohorts in Wave Life Sciences’ mid-stage trial of WVE-007, higher baseline body mass index and excessive body fat have been associated with a more pronounced effect, Rodman & Renshaw said following the company’s ObesityWeek update.

By BioSpace

1 min read
ObesityWeek 2026: Wave outlines case for body composition–based trial design
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights